The Commonwealth Fund
Former FDA Commissioner Jane Henney, MD, elected to board of directors. Henney is a senior scholar at the Association of Academic Health Centers (1"The Pink Sheet" April 30, In Brief)
You may also be interested in...
Former FDA Commissioner Jane Henney, MD, joins AHC as senior scholar-in-residence, an unpaid position, where she is writing on a variety of topics including nursing shortages and healthcare access. The former University of New Mexico VP-health sciences is likely to return to academia
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials